Table 2 Number of individuals that accessed specific free public health goods and services, by population group
| Â | Immunisation | Insecticide-treated bets (ITNs) | Anti-malaria drugs | Ante-natal care (ANC) | Child-birth service | Anti-retroviral drugs (ARVs) | Family Planning services (FP) | Treatment of tuberculosis (TB) |
|---|---|---|---|---|---|---|---|---|
| Â | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) |
Utilization by urban-rural residence | ||||||||
Urban n = 12,745 (57.4%) | 1,649 (55%) | 308 (98%) | 22 (36%) | 16 (73%) | 1 (33%) | 0 (0%) | 0 | 1 (14%) |
Rural n = 9,473 (42.6%) | 1,343 (45%) | 5 (2%) | 39 (54%) | 6 (27%) | 2 (67%) | 1 (100%) | 0 | 6 (86%) |
Chi-square (p-value) | 45.2 (.0001) | 278.9 (.0001) | 8.1 (.003) | 3.0 (.064) | .55 (.43) | 1.2 (.45) | N/A | 4.8 (.034) |
Utilization by gender | ||||||||
Male n = 10,069 (45.5%) | 1,429 (48%) | 107 (34%) | 21 (34%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 | 3 (43%) |
Female n = 12,062 (54.5%) | 1,563 (52%) | 206 (66%) | 40 (66%) | 22 (100%) | 3 (100%) | 1 (100%) | 0 | 4 (57%) |
Chi-square (p-value) | 60.3 (.0001) | 18.6 (.0001) | 3.21 (.047) | 18.8 (.0001) | 2.5 (.16) | .85 (.54) | N/A | .027 (.60) |
Utilization by SES | ||||||||
Quintile 1 n = 4,437 (20%) | 604 (20.2%) | 29 (9.3%) | 25 (41%) | 2 (9%) | 1 (33%) | 0 (0%) | 0 | 2 (29%) |
Quintile 2 n = 4,443 (20%) | 664 (22.2%) | 59 (18.9%) | 8 (13%) | 2 (9%) | 0 (0%) | 0 (0%) | 0 | 2 (29%) |
Quintile 3 n = 4,425 (19.9%) | 585 (19.6%) | 56 (17.8%) | 8 (13%) | 1 (5%) | 1 (33%) | 0 (0%) | 0 | 2 (29%) |
Quintile 4 n = 4,431 (19.9%) | 569 (19.0%) | 94 (30%) | 12 (20%) | 12 (55%) | 1 (33%) | 0 (0%) | 0 | 1 (14%) |
Quintile 5 n = 4,433 (20%) | 570 (19.1%) | 75 (24%) | 8 (13%) | 5 (23%) | 0 (0%) | 1 (100%) | 0 | 0 (0%) |
Chi-square (p-value) | 64.6 (.0001) | 55.6 (.0001) | 15.3 (.005) | 15.4 (.04) | 2.22 (.73) | 4.3 (.37) | N/A | 2.8 (.72) |
Concentration index (CI) | −0.02 | 0.17 | −0.20 | 0.27 | −0.13 | - | - | −0.29 |
Total | 2,992 | 313 | 61 | 22 | 3 | 1 | 0 | 7 |